TRIKAFTA (elexacaftor, ivacaftor and tezacaftor) for the Treatment of Cystic Fibrosis

3l-Image—TRIKAFA
TRIKAFTA was approved based on the results of two phase three clinical trials. Credit: Vertex Pharmaceuticals Incorporated.